Rapid Therapeutic Science Laboratories, Inc. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/34c2576e-867e-4aa3-bdc2-240b8111ae1d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-2.9M | 2021-01-01 – 2021-12-31 | evidence 0001393905-22-000069 |
| FY 2020 | $-2.1M | 2020-01-01 – 2020-12-31 | evidence 0001393905-22-000069 |
| FY 2019 | $-624.6k | 2019-04-01 – 2020-03-31 | evidence 0001393905-20-000203 |
| FY 2018 | $-348.8k | 2018-04-01 – 2019-03-31 | evidence 0001393905-19-000220 |
| FY 2017 | $-2.6M | 2017-04-01 – 2018-03-31 | evidence 0001393905-18-000353 |
| FY 2016 | $-21.6k | 2016-04-01 – 2017-03-31 | evidence 0001393905-17-000206 |
| FY 2015 | $-12.0k | 2015-04-01 – 2016-03-31 | evidence 0001393905-16-000952 |
| FY 2014 | $-12.3k | 2014-04-01 – 2015-03-31 | evidence 0001393905-16-000952 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Rapid Therapeutic Science Laboratories, Inc. — all facts · Revenue · Operating Income